FDA approves Sunovion’s Latuda for schizophrenia: http://finance.yahoo.com/news/FDA-Approves-OnceDaily-LATUDA-bw-1315163755.html?x=0&.v=1 Sunovion is the new name for the Sepracor subsidiary of Dainippon Sumitomo.